Health and medicine are essential for human welfare. Advances in genetics, in testing and in diagnosis are improving rapidly.
AI will help us live longer than we every expected. Not just to 120. We may be able to live to hundreds. We are in the midst of a healthspan revolution that will enable us to live vitally. Advanced diagnostics to catch any disease at inception. Tailored advanced therapies to reverse disease. Slowing, stopping, and potentially even reversing aging.
AI Helps Us Live Longer Read More »
Human 3D organoids are in vitro 3D cultures that mimic the structure and function of human organs. They are derived from stem cells, which can self-renew and differentiate into various cell types. Organoids are a powerful in disease modelling, drug development, personalised treatment, and regenerative medicine.
Human 3D Organoids Read More »
AI is transforming clinical trials by predicting success with 90% accuracy. This could lead to fewer trials, better outcomes, and reduced trial times. Companies like OPYL, OpenAI, and Moderna are at the forefront of this AI-driven healthcare revolution. Using 20 years of past clinical trial data, OPYL can improve trial outcomes by 4 to 5 times, reducing costs and improving success.
AI Improves Clinical Trials Read More »
Within a decade we will cure disease, not just treat it. AI accelerates drug discovery and will reduce cost of new drugs by 4 from $2.4 billion to $600 million, and time from 14 years to 6 years. ROI improves 12 times. AI in medicine will not just improve medicines but will improve diagnosis and treatment.
AI Accelerates Drug Discovery Read More »
New research from Prof Ali Max reveals the COVID-19 spike protein can persist in the body for years, causing brain damage. The protein accumulates in the skull and meninges, leading to inflammation, neuronal damage, and neurodegenerative changes. Long COVID patients exhibit elevated levels of neurodegenerative markers. Vaccination can significantly reduce spike protein accumulation and long-term neurological effects.
Stroke is a major health issue, especially for those over 60. Statins lower cholesterol, stabilize plaques, and reduce inflammation, effectively preventing repeat strokes. However, evidence for statins preventing first strokes in the elderly, particularly those over 75, is weaker, leading to inconsistent guidelines.
Statin Effectiveness in Older People Read More »
About one in eight people who get covid-19, also get long covid which is post-infection symptoms persisting for at least a month. Long covid impacts young and is cumulative. Loss of IQ. Loss of fitness, and for some months or years of pain. Long covid is real. Prevention is needed. Masks. Vaccines. Ventilation
Long Covid Impacts Updated Read More »
The Human Cell Atlas project is revolutionizing our understanding of human biology with its 37 trillion cells and will transform medicine and healthcare. The Atlas provides not only the DNA, but where and how the RNA and control mechanisms operate
It is a testament to the power of collaborative research and the potential of big data to drive scientific discovery.
We have all heard or know of someone who is taking the obesity drug but the exciting news is research going to take the obesity GLP-1 drugs for wider use. A science paper summary of the GLP-1 advances shows how researchers are focusing on other uses.
Obesity GLP-1 Drug Use Read More »
Ozempic and other GLP-1 receptor agonists have swept the world for obesity and type 2 diabetes. Their extended value is reducing inflammation and improving clinical outcomes in heart disease by 20% or more. Kidney diseases along with promising but less consistent evidence in liver diseases, while research in autoimmune diseases and dementia remains preliminary.
Ozempic and GLP-1 Drugs Read More »
The Expanded Programme on Immunization (EPI) has been a cornerstone of global health, saving over 150 million lives and improving health outcomes worldwide. Through its comprehensive approach and the impact of vaccines like measles, EPI has demonstrated the power of vaccination in reducing mortality, promoting equity, and protecting individuals throughout their lifespan.
Vaccines Saved 154 million Lives Read More »
Recent advancements in AI, particularly in early diagnosis and treatment of dementia, provide a glimmer of hope. Dementia, a major global health challenge, is expected to affect 153 million by 2050. AI detection and lifestyle changes like exercise can delay onset, while new drugs like Donanemab offer promising, albeit expensive, therapies.
Dementia Diagnosis and Treatment Advances Read More »
Cancer, heart and lifestyle diseases are rising. Dr Synder from Harvard shows better measuring of health function using AI and wearable monitors assist in changing lifestyle diseases. Prevention is better than cure, and early detection saves lives.
Fitness Wearables For Disease Prevention Read More »
What is zero population growth? It is associated with carrying capacity or what is sustainable and equitable. Can the earth support 2 billion or 40 billion people? Population, food, energy house and labour workforce are discussed
Zero Population Growth & Carrying Capacity Read More »
Are there too many people on the planet and who will volunteer for euthanasia. Or is this over stated and we can live sustainably with the 8 billion people
Earth’s Population is Too High Read More »
